The Longevity Week: Master Investor Masterclass
The Investment Panel investigates demonstrated Longevity growth, name-checking some hot areas for investment, seeing how Longevity-ready institutional investors are...
AgeX commercialises its stem cell lines with continued support from stakeholder Juvenescence.
Biotech AgeX Therapeutics reported financial and operating results for the third quarter ended...
The Longevity Week: Master Investor Masterclass
It was the Longevity Forum's Longevity Week this week and this Science Panel, supported by Master Investor, benchmarks current...
A new early-stage longevity investment fund in the Baltics gets underway targeting seed and pre-A Longevity rounds.
Latvian investment group LongeVC has announced its first...
Tom Britton steps up from Longevity firm’s Advisory Panel to full Board member.
Earlier this year, SyndicateRoom co-founder Tom Britton joined First Longevity’s Advisory Panel....
Biostrap raising funds to open up consumer wearable tech for businesses to build their own biometric monitoring platforms.
Since 2016, Los Angeles based wearable tech...
We speak to the founder of Aimee Health – currently raising seed funding for its nutrition monitoring AI platform.
Californian nutrition health start-up Aimee Health is on...
Whoopee! Health monitoring firm bags $100 million in funding: WHOOP valued at $1.2 billion in Series E financing led by IVP.
Health monitoring company WHOOP...
Quicksilver's liposomal delivery system boasts a non-invasion of the body patchers.
Colorado-based Quicksilver Scientific manufactures a range of supplements from immunity boosters to NAD+. By...
Master Investor is a publication that helps private investors to take charge of their financial destiny: covering a range of subjects, from shares to...
Following an R&D collaboration that began last year, Japanese pharma Astellas has announced it will acquire bioelectronics firm iota in $304m deal.
Last year's R&D...
It's an online conference, but not as you know it. Say goodbye to Zoom fatigue and hello to Neurotech2020.
Understanding the brain, consciousness and thought...
Breanna Deutsch joins us for a guest editorial to advocate for the increased prioritisation of government funding for Longevity in the US.
Breanna Deutsch has...
Some news of our own: Key investors join the First Longevity funding round.
Among those participating in this second stage funding for First Longevity are...
Jinfiniti, NetraMark and Scarlette Lillie will explore the role psilocybin can play for age-related diseases.
Augusta University spin-out Jinfiniti was our first Startup Showcase, and they...
European Longevity Initiative writes an open letter addressing concerns that the European Research Council's budget has been cut.
Suggested changes to the proposed ERC budget...
Keystone Bio seeks funding as it gears up for clinical trials of therapeutic targeting the “keystone pathogen” of chronic inflammaging.
Lurking in the mouths of...
Hyperbaric oxygen therapy can significantly decrease aging characteristics – does it have a future as a commercial Longevity treatment?
Aging is made up of many...
Targeting senescent “zombie” cells may improve cancer survival rates.
How well women with cervical cancer respond to treatment (and survive) correlates with the level of...
![Ozone therapy recently hit the headlines as one of the many treatment options being examined to mitigate the effects of COVID-19 [1], but it is also showing great promise in the treatment of neurodegenerative conditions such as Alzheimer’s and Parkinson's.](https://www.longevity.technology/wp-content/uploads/2020/10/Ozone-therapyW-218x150.jpg "Stopping neurodegeneration in its tracks with ozone therapy")
